Patent US4358442A successfully refreshed from Google Patents.
US4358442A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Rosmarinic acid-phospholipide-complex
Assignee: A Natterman und Cie GmbH
•
Filing: 1980-12-11
•
Granted: 1982-11-09
•
Expires: 2000-12-11
Abstract
Abstract The present invention is directed to a new rosmarinic acid-phospholipide-complex product containing rosmarinic acid and the phospholipide in a molar ratio of 1:2. The invention is further directed to a process for producing the same and to pharmaceutical preparations containing the same.
Inventors
- 👤 Ferdinand Wirtz-Peitz
- 👤 Manfred Probst
- 👤 Johannes Winkelmann
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-05 10:36
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/66; A61K31/683; A61K31/685; A61K31/185; A61K31/19; A61K47/00; A61K47/50; A61K47/51; A61K47/54; A61K47/543; A61K47/544; A61P; A61P29/00; C; C07; C07F; C07F9/00; C07F9/02; C07F9/06; C07F9/08; C07F9/09; C07F9/10; C07F9/106
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
2 words
Rosmarinic acid-phospholipide-complex.
Claim 2
Dependent Claim
2 words
Rosmarinic acid-phospholipide-complex.
Claim 3
Dependent Claim
19 words
Rosmarinic acid-phospholipide-complex according to claim 1 wherein 2 moles of phospholipide are present per each mole of rosmarinic acid.
Claim 4
Dependent Claim
16 words
Complex according to claim 1 characterized in that the phospholipide is a natural or synthetic phospholipide.
Claim 5
Dependent Claim
14 words
Complex according to claim 3 wherein the phospholipide is a natural or synthetic phosphatidylcholine.
Claim 6
Dependent Claim
18 words
Complex according to claim 4 characterized in that the phospholipide is phosphatidylcholine, hydrogenated phosphatidylcholine or calcium phosphatidylcholine chloride.
Claim 7
Dependent Claim
31 words
Process for the production of the rosmarinic acid--phospholipide-complex as claimed in claim 2 wherein rosmarinic acid is subjected to reaction with a phospholipide in a molar proportion of 1:2 with stirring.
Claim 8
Dependent Claim
17 words
A pharmaceutical preparation comprising a pharmaceutically effective amount of a rosmarinic acid-phospholipide-complex as claimed in claim 1.
References Cited (Backward Citations)
US4271196A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1985-11-08 | 1986-05-10 | 1986-11-09 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1989-11-08 | 1990-05-10 | 1990-11-09 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1993-11-08 | 1994-05-10 | 1994-11-09 | $7700.00 | Window Closed / Lapsed |